Fezolinetant, an Investigational Drug for the Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause (VMS)
Event Type:
Webinars
Date:
Tuesday, Dec. 6, 2022, 2-3pm ET
Member:
Free
Non-Member:
Free
